One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
Title:
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
Author:
van Dijk, Myrthe J. Rab, Minke A. E. van Oirschot, Brigitte A. Bos, Jennifer Derichs, Cleo Rijneveld, Anita W. Cnossen, Marjon H. Nur, Erfan Biemond, Bart J. Bartels, Marije Jans, Judith J. M. van Solinge, Wouter W. Schutgens, Roger E. G. van Wijk, Richard van Beers, Eduard J.